Results 1 to 10 of about 30,694 (295)

Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles. [PDF]

open access: yesPCN Rep
Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Kishi Y, Takumi I, Nakajima-Ohyama KC.
europepmc   +2 more sources

Correction: Breast milk Δ9-tetrahydrocannabinol in cannabis users during the postpartum period: correlation between breast milk, maternal urine and saliva samples during early lactation. [PDF]

open access: yesFront Psychiatry
Sandonís M   +9 more
europepmc   +1 more source

Marijuana and Delta-8-THC Use Among U.S. Adolescents Between 2023 and 2024. [PDF]

open access: yesAm J Prev Med
Harlow AF   +6 more
europepmc   +1 more source

Cannabis Is Associated With Potentially Proatherogenic Inflammation in Youth. [PDF]

open access: yesCirc Res
Kelesidis T   +9 more
europepmc   +1 more source

Breast milk Δ9-tetrahydrocannabinol in cannabis users during the postpartum period: correlation between breast milk, maternal urine and saliva samples during early lactation. [PDF]

open access: yesFront Psychiatry
Sandonís M   +9 more
europepmc   +1 more source

Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry. [PDF]

open access: yesAust N Z J Obstet Gynaecol
Ahmed T   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy